Latest Media News

Credit Corp Group Limited reported a robust 14.6% revenue increase and an 85.6% jump in profit after tax for the year ended June 2025, alongside a significant dividend hike.

Lake Resources has released an updated feasibility study for its Kachi lithium brine project, revealing significant capital and operating cost reductions that enhance the project's competitive edge in the lithium market.

Sky New Zealand has finalized its acquisition of Discovery NZ Limited for a nominal sum, aiming to leverage significant cost synergies and diversify revenue streams. Despite Discovery NZ’s recent losses, Sky projects a positive cash flow impact and a pathway to meaningful earnings growth by FY28.

Thrive Tribe Technologies reports early commercial traction with its new digital services model, alongside a completed 20 – 1 capital consolidation and ongoing funding initiatives.

IRIS Metals has successfully completed test mining at its fully permitted Beecher lithium project and expanded its US footprint with a strategic acquisition, while securing $4.27 million to fund ongoing exploration and development.

Sportshero Ltd’s latest quarterly cash flow report reveals ongoing operational cash outflows balanced by financing activities, leaving the company with just over two quarters of funding runway.

Victor Group Holdings delivered a positive net operating cash flow of $586k in the June 2025 quarter, driven by its cloud services and e-learning segments, while maintaining a healthy cash position and no external debt.

Airtasker Limited has reported its second consecutive year of positive free cash flow alongside robust revenue growth, fueling accelerated expansion in the UK and US marketplaces.

Airtasker Limited reports its second consecutive year of positive free cash flow alongside a 29% jump in marketplaces revenue, driven by explosive growth in the UK and US markets.

Amplia Therapeutics reports encouraging ACCENT trial results for its FAK inhibitor narmafotinib, including rare complete responses in pancreatic cancer, alongside a $27.5 million capital raise to fund ongoing clinical development.

Vection Technologies capped FY25 with its highest monthly order intake ever, driven by defence and AI/XR contracts, while posting positive pro-forma cash flow despite payment timing issues.

INOVIQ Limited reports breakthrough results for its ovarian cancer screening test achieving perfect early-stage detection, alongside promising advances in its CAR-exosome cancer therapy program.